Tchaikapharma High Quality Medicines AD (BUL: THQM)
Health Care · Pharmaceuticals · BG
€7.10
-1.39% today · -13.1% 1Y
Tchaikapharma High Quality Medicines AD (BUL: THQM) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $839.34M.
Over the last twelve months the share price has lost 13.1%, trading between 4.42 and 9.04.
Tweenvest scores Tchaikapharma High Quality Medicines AD across four factors: quality 73/100, value 63/100, growth 76/100. Its strongest factor is growth.
THQM price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $839.34M
- Revenue (TTM)
- $41.61M
- P/E
- 231.26
- EPS
- 0.03
- Dividend yield
- —
- Beta (5Y)
- 0.08
- 52-week high
- €9.04
- 52-week low
- €4.42
- Avg volume (3M)
- —
- Shares outstanding
- 101.30M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.